Who owns Faeth Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of FTH from SEC Form 13F filings across 79 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 79 institutions disclosed 19.6M shares of Faeth Therapeutics, Inc. worth $578.6M — about 75.9% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
79
13F holders
$578.6M
value, 2026 filers
75.9%
of shares outstanding (19.6M sh)
41
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of FTH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 2.3M | $68.7M | 1.6% | 8.9% | +14.4% |
| 2 | Avoro Capital Advisors LLC | 1.4M | $41.9M | 0.4% | 5.5% | -2.4% |
| 3 | Polar Capital Holdings PlcNEW | 1.3M | $38.2M | 0.1% | 5% | new |
| 4 | Balyasny Asset Management L.P. | 1.2M | $34.3M | 0.0% | 4.5% | +10.7% |
| 5 | Cormorant Asset Management, LP | 1.0M | $30.6M | 2.1% | 4% | 0.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 951,721 | $28.3M | 0.0% | 3.7% | +9309.0% |
| 7 | Trails Edge Capital Partners, LP | 941,689 | $28.0M | 4.0% | 3.6% | +82.7% |
| 8 | Caligan Partners LP | 890,210 | $26.5M | 1.6% | 3.4% | +41.4% |
| 9 | Vivo Capital, LLC | 844,576 | $25.1M | 2.8% | 3.3% | +17.0% |
| 10 | BAKER BROS. ADVISORS LP | 803,425 | $23.9M | 0.1% | 3.1% | -37.5% |
| 11 | Fairmount Funds Management LLC | 722,020 | $21.5M | 1.3% | 2.8% | 0.0% |
| 12 | AMERIPRISE FINANCIAL INCNEW | 682,494 | $20.3M | 0.0% | 2.6% | new |
| 13 | B Group, Inc. | 610,169 | $18.1M | 11.2% | 2.4% | 0.0% |
| 14 | FRANKLIN TEMPLETON INC | 517,982 | $10.4M | 0.0% | 2% | +4.7% |
| 15 | CITADEL ADVISORS LLC | 450,626 | $13.4M | 0.0% | 1.7% | +3564.8% |
| 16 | BlackRock, Inc. | 414,823 | $12.3M | 0.0% | 1.6% | +12093.5% |
| 17 | STEMPOINT CAPITAL LPNEW | 404,921 | $12.0M | 2.2% | 1.6% | new |
| 18 | UBS Group AG | 369,972 | $11.0M | 0.0% | 1.4% | +1617.5% |
| 19 | Woodline Partners LPNEW | 361,223 | $10.7M | 0.0% | 1.4% | new |
| 20 | Candriam S.C.A.NEW | 319,663 | $9.5M | 0.0% | 1.2% | new |
| 21 | STATE STREET CORPNEW | 311,427 | $9.3M | 0.0% | 1.2% | new |
| 22 | Integral Health Asset Management, LLCNEW | 240,000 | $7.1M | 0.4% | 0.9% | new |
| 23 | GEODE CAPITAL MANAGEMENT, LLC | 231,865 | $6.9M | 0.0% | 0.9% | +1486.4% |
| 24 | BOOTHBAY FUND MANAGEMENT, LLC | 223,312 | $6.6M | 0.1% | 0.9% | +67.1% |
| 25 | RA CAPITAL MANAGEMENT, L.P. | 205,060 | $6.1M | 0.1% | 0.8% | -71.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.